Section 3(d) of the Indian Patents Act limits patentability for new forms or uses of known substances unless enhanced efficacy is proven. The Novartis case illustrates how courts interpret this provision, focusing on therapeutic efficacy rather than mere improved properties.
Read more about Patentability of New Form, Use or Property – Section 3(d)Category: Patents
Who Must Pay for Appointment of Scientific Advisors? Vittal Mallya Scientific Research Foundation Vs. Indfrag Limited
The post explores a court’s decision on who must pay for scientific advisors in Indian patent cases, focusing on Section 115 of the Patents Act. It analyses the reasoning behind the judgment and comments on professional conduct during litigation.
Read more about Who Must Pay for Appointment of Scientific Advisors? Vittal Mallya Scientific Research Foundation Vs. Indfrag LimitedCan use of an invention in a movie infringe a patent?
This article discusses the conditions under which using a patented invention in a movie may constitute patent infringement under Indian law. It differentiates between actual use and depiction, and addresses the exhaustion of rights.
Read more about Can use of an invention in a movie infringe a patent?Patent and Public Domain Balance 2 – Patentability Requirements
This article explores the essential requirements for patentability and their function in shaping the boundary between patent protection and the public domain. It discusses the influence of the TRIPS Agreement and national discretion on patent standards.
Read more about Patent and Public Domain Balance 2 – Patentability RequirementsPatent and Public Domain Balance – 1
This article explores the relationship between exclusive patent rights and the public domain under Indian patent law. It discusses how incentives and access impact innovation and technological progress, and outlines the challenges in achieving the right balance.
Read more about Patent and Public Domain Balance – 1Shall We Amend the Claims During Litigation?- AGC Flat Glass Europe Sa vs Anand Mahajan And Ors
The post discusses whether patent claim amendments should be permitted during litigation, highlighting the Delhi High Court’s approach in the AGC Flat Glass case. It critically evaluates the legal and procedural implications of such amendments within the Indian patent system.
Read more about Shall We Amend the Claims During Litigation?- AGC Flat Glass Europe Sa vs Anand Mahajan And OrsOpen Source Software and Patent Risks
This article analyses the patent risks associated with open source software, focusing on legal challenges, real-world cases, and mitigation strategies. It provides practical guidance for developers and companies using OSS within the Indian legal framework.
Read more about Open Source Software and Patent RisksCase Review: Garaware v. Techfeb
This case review analyses the Garware v Techfeb patent, focusing on the specification’s drafting and the relevance of prior art. The post raises questions about the invention’s novelty and examines the omission of gabion systems in the background section.
Read more about Case Review: Garaware v. TechfebGaraware Vs Techfeb
This post examines the Garaware vs Techfeb patent dispute, focusing on claim construction and essential features under Indian patent law. It analyses the clarity and novelty of the patent claim and outlines next steps for further legal analysis.
Read more about Garaware Vs TechfebLife of a Gene in India
This analysis addresses the uncertain legal landscape for gene patents in India, with a focus on isolated and purified gene sequences. The author calls for clearer guidelines and consistent application of patent law by the Indian Patent Office.
Read more about Life of a Gene in India